Champions Oncology Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.3% | -2.4% | -4.6% | +1.2% | +21.3% | +5.6% | -5.6% | -1.3% | -5.7% | -5.1% | +23.3% | |
| – | -5.8% | +3.3% | -3.4% | +6.9% | +39.9% | +13.6% | -6.1% | +1.5% | -5.4% | -4.8% | +0.4% | |
| – | -19.0% | -41.4% | +10.5% | -4.8% | +16.3% | +205.6% | +5.5% | -17.5% | -16.3% | -31.6% | -10.6% | |
| – | -19.0% | -41.4% | +10.5% | -4.8% | +16.3% | +205.6% | +5.5% | -17.5% | -16.3% | -31.6% | -10.6% | |
| – | +2.2% | +20.7% | -5.2% | +15.9% | +50.7% | -28.8% | -15.7% | +21.8% | +4.6% | +9.2% | +3.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +2.3% | -2.8% | -9.9% | -2.8% | +2.4% | +13.6% | -5.5% | -4.0% | -7.2% | -4.8% | +25.8% | |
| – | +4.9% | -1.9% | -11.0% | -1.6% | +5.3% | +20.0% | -4.8% | -2.5% | -6.6% | -3.7% | -6.0% | |
| – | +2.4% | +2.5% | +2.4% | +2.3% | +2.4% | +2.6% | +2.4% | +1.3% | +5.4% | -0.5% | -45.7% | |
| – | +4.9% | +22.0% | -9.7% | -7.3% | +4.9% | -16.6% | +14.1% | +23.7% | -4.5% | +20.6% | +20.4% | |
| – | -2,312.9% | – | – | – | +703.1% | -31.0% | -7.0% | +18.9% | +2.7% | -8.0% | -1.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +0.0% | +3.3% | -0.2% | +2.5% | -4.3% | +0.3% | +4.9% | -3.9% | -0.4% | +0.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.